L1:
Pfizer will make their decision on the results, and decide if the IP can be used in more current and future drugs.
If they "believe" , then a big $$payday could follow?
So this IP acceptance by Pfizer is the crucial part.
Anecdotally I believe things are positive, but who knows?
The beauty of Pfizers involvement with the platform is that these trials should not take too long, because they're not testing a new drug. Hopefully not too far away from negotiating a deal for SUDA?
If so, how good are the negotiating skills of a small biotech staff against a huge pharma?
Pfizer OTC, page-49
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $183.9M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $22.60K | 132.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 96763 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 696241 | 7 |
View Market Depth
| Last trade - 10.00am 24/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |